NEW YORK (GenomeWeb News) — Tm Bioscience today said third-quarter revenues increased 19 percent as R&D spending rose 98 percent and loss increased 83 percent.
 
Total receipts for the three months ended Sept. 30 increased to $2.6 million from $2.2 million year over year.
 
Tm said $2.3 million of its sales came from its Tag-It reagents, and $300,000 came from instrument sales, an increase of 50 percent from a year ago.  
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The ancestors of the Arizona bark scorpion and other scorpions and spiders underwent whole-genome duplication, KJZZ reports.

A cryptographic approach could help researchers keep genomic data private while researchers analyze it, Scientific American reports.

Andy Page, the former president of 23andMe, has joined a diabetes-management startup, according to CNBC.

In Cell this week: regulatory changes in pancreatic cancer, metabolic shifts in Alzheimer's disease, and more.